Skip to content
Trial Agents

Nova-Clin Medical Research Center

Nova-Clin Medical Research Center is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

2distinct trials
6recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 2 of 2 trials · Latest update first

A Multicenter, Open-label, Randomized Phase 3 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) vs Investigator Choice of Single-agent Chemotherapy as Third-line Treatment in Subjects with Advanced / Metastatic Non-Small Cell Lung Cancer (NSCLC)

Sponsor Maia Biotechnology Inc.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Nova-Clin Medical Research Center?

The 2026-10-09 snapshot links Nova-Clin Medical Research Center to 2 distinct CTIS trials. Recorded services include Clinical monitoring, CRO for Romania, Bulgaria, Safety reporting & pharmacovigilance, Investigator recruitment, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Nova-Clin Medical Research Center?

The most frequently recorded therapeutic areas are Respiratory, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Nova-Clin Medical Research Center conducted?

The linked trials record locations in 7 countries, including Hungary, Poland, Romania, Bulgaria, Spain. These are trial locations, not confirmed office locations or countries where Nova-Clin Medical Research Center delivered services.

What can this page tell me about Nova-Clin Medical Research Center's trial experience?

Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Nova-Clin Medical Research Center. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Nova-Clin Medical Research Center S.R.L.

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.